$31.37
-1.06-3.27%
In chiusura: Nov 20, 4:00 PM EST
$31.37
N/A
Post-mercato: 4:00 PM EST

The average analyst price target for Maze Therapeutics is $62.09, 97.9% above the current price. Of 11 analysts, 11 rate it Buy. Targets range from $28 to $110. The latest change came on Nov 11, 2026, when JP Morgan lowered its price target on Maze Therapeutics from $53 to $51 and kept an Overweight rating.
Price Target Range — 8 Quarters
Analyst Consensus — 11 Analysts
Rating Trend — Last 9 Months